Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical study Post author:admin Post published: July 14, 2026 Post category:uncategorized A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. You Might Also Like Revolutionary hand-held scanner enhances 3D imaging for early disease diagnosis September 30, 2024 Parasitic worm evades detection by suppressing skin neurons August 11, 2025 Study shows how troriluzole can target early-stage alterations associated with Alzheimer’s September 3, 2024
Study shows how troriluzole can target early-stage alterations associated with Alzheimer’s September 3, 2024